Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1Phase 1/2 1

Status

Completed 5

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 56Gastrointestinal 54Genitourinary 27Head & Neck 22Dermatologic 21Gynecologic 19Breast 13Lymphoid 5Other solid neoplasm 4CNS 3Sarcoma 2Endocrine 2NET 1

Conditions

Lymphoma 2571Precursor Cell Lymphoblastic Leukemia-Lymphoma 2086Lymphoma, Non-Hodgkin 2058Leukemia, Lymphocytic, Chronic, B-Cell 1771Lymphoma, Follicular 1652Lymphoma, Large B-Cell, Diffuse 1597Leukemia 1172Hodgkin Disease 1128Lymphoma, Mantle-Cell 1110Burkitt Lymphoma 887Leukemia, Myeloid, Acute 885Lymphoma, B-Cell, Marginal Zone 788Recurrence 779Multiple Myeloma 744Lymphoma, B-Cell 704Myelodysplastic Syndromes 615Neoplasms 494Lymphoma, T-Cell, Cutaneous 479Waldenstrom Macroglobulinemia 470Lymphoma, Large-Cell, Immunoblastic 456Mycosis Fungoides 383Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 382Lymphoma, Large-Cell, Anaplastic 362Sezary Syndrome 321Lymphoma, T-Cell, Peripheral 321Leukemia, Myelogenous, Chronic, BCR-ABL Positive 307Hematologic Neoplasms 299Myeloproliferative Disorders 288Neoplasms, Plasma Cell 270Blast Crisis 261

Interventions

pembrolizumab 5Gemcitabine 1Brentuximab Vedotin 1Bendamustine Hydrochloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Parkinson Disease 4, Autosomal Dominant Lewy Body × Lymphoid × Clear all
NCT02684292 2026-02-18

MK-3475-204

Merck Sharp & Dohme LLC

Phase 3 Completed
304 enrolled 1 FDA
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Hodgkin Disease

NCT03598608 2026-02-05

MK-4280-003

Merck Sharp & Dohme LLC

Phase 1/2 Completed
137 enrolled
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Hodgkin Disease, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell

NCT05508867 2026-01-20

MK-4280A-008

Merck Sharp & Dohme LLC

Phase 2 Completed
203 enrolled
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Hodgkin Disease

NCT03010176 2025-10-29

MK-1454-001

Merck Sharp & Dohme LLC

Phase 1 Completed
156 enrolled 20 charts
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lymphoma

NCT04317066 2025-04-06

KEYNOTE-A33

Merck Sharp & Dohme LLC

Phase 1 Completed
7 enrolled 13 charts
Lymphoid

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡